Wolverton Garden

Wolverton Garden is a private biotechnology company focused on the development of novel therapeutic candidates for high-unmet-need areas, including oncology and rare diseases. The company operates primarily as a lean, virtual drug development entity, leveraging a network of academic and industry partners to advance its early-stage pipeline. Its business model emphasizes the identification and de-risking of promising biological targets before transitioning programs into formal clinical development. Wolverton Garden maintains a focus on small molecule modalities and innovative mechanisms of action to address complex disease pathologies.